Hearing how a family found meaning in the midst of their loss reminds columnist Kristin Neva that she isn't alone in her grief with ALS.
For columnist Dagmar Munn, reducing uncertainty in one area of her life with ALS would mean keeping her ALS progression right where it is.
Insmed has launched a Phase 1 clinical trial testing INS1202, an experimental gene therapy for ALS. INS1202 is designed to reduce levels of the toxic SOD1 protein implicated in some ALS cases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results